Return On Assets of Viracta Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viracta Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 30 Sep 2024.
  • Viracta Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2024 was -114%, a 95% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2023 was -71%, a 33% decline from 2022.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2022 was -54%, a 43% increase from 2021.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2021 was -94%, a 64% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Viracta Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -114% -56% -95% 01 Jul 2024 30 Sep 2024
Q2 2024 -93% -31% -50% 01 Apr 2024 30 Jun 2024
Q1 2024 -80% -22% -38% 01 Jan 2024 31 Mar 2024
Q4 2023 -71% -18% -33% 01 Oct 2023 31 Dec 2023
Q3 2023 -59% -5% -10% 01 Jul 2023 30 Sep 2023
Q2 2023 -62% -16% -35% 01 Apr 2023 30 Jun 2023
Q1 2023 -58% -17% -41% 01 Jan 2023 31 Mar 2023
Q4 2022 -54% +40% +43% 01 Oct 2022 31 Dec 2022
Q3 2022 -53% +49% +48% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% +70% +60% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% +117% +74% 01 Jan 2022 31 Mar 2022
Q4 2021 -94% -37% -64% 01 Oct 2021 31 Dec 2021
Q3 2021 -102% -70% -220% 01 Jul 2021 30 Sep 2021
Q2 2021 -116% -81% -235% 01 Apr 2021 30 Jun 2021
Q1 2021 -158% -115% -266% 01 Jan 2021 31 Mar 2021
Q4 2020 -57% -7% -15% 01 Oct 2020 31 Dec 2020
Q3 2020 -32% +59% +65% 01 Jul 2020 30 Sep 2020
Q2 2020 -35% +80% +70% 01 Apr 2020 30 Jun 2020
Q1 2020 -43% +73% +63% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% +74% +60% 01 Oct 2019 31 Dec 2019
Q3 2019 -91% +13% +12% 01 Jul 2019 30 Sep 2019
Q2 2019 -115% +11% +8.6% 01 Apr 2019 30 Jun 2019
Q1 2019 -116% +14% +10% 01 Jan 2019 31 Mar 2019
Q4 2018 -124% +5% +3.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -104% +22% +17% 01 Jul 2018 30 Sep 2018
Q2 2018 -126% -14% -12% 01 Apr 2018 30 Jun 2018
Q1 2018 -130% -21% -19% 01 Jan 2018 31 Mar 2018
Q4 2017 -129% -22% -21% 01 Oct 2017 31 Dec 2017
Q3 2017 -126% -14% -12% 01 Jul 2017 30 Sep 2017
Q2 2017 -112% -10% -9.5% 01 Apr 2017 30 Jun 2017
Q1 2017 -109% -15% -16% 01 Jan 2017 31 Mar 2017
Q4 2016 -106% -15% -16% 01 Oct 2016 31 Dec 2016
Q3 2016 -112% -45% -67% 01 Jul 2016 30 Sep 2016
Q2 2016 -102% -22% -27% 01 Apr 2016 30 Jun 2016
Q1 2016 -94% -16% -20% 01 Jan 2016 31 Mar 2016
Q4 2015 -91% -14% -18% 01 Oct 2015 31 Dec 2015
Q3 2015 -67% +23% +25% 01 Jul 2015 30 Sep 2015
Q2 2015 -81% -5% -7.1% 01 Apr 2015 30 Jun 2015
Q1 2015 -79% -7% -9.6% 01 Jan 2015 31 Mar 2015
Q4 2014 -78% -8% -12% 01 Oct 2014 31 Dec 2014
Q3 2014 -90% -35% -65% 01 Jul 2014 30 Sep 2014
Q2 2014 -75% -13% -21% 31 Mar 2014 30 Jun 2014
Q1 2014 -72% -4% -5.3% 01 Jan 2014 31 Mar 2014
Q4 2013 -69% +11% +14% 01 Oct 2013 31 Dec 2013
Q3 2013 -54% +47% +47% 01 Jul 2013 30 Sep 2013
Q2 2013 -62% +30% +32% 01 Apr 2013 30 Jun 2013
Q1 2013 -68% +13% +16% 01 Jan 2013 31 Mar 2013
Q4 2012 -80% 01 Oct 2012 31 Dec 2012
Q3 2012 -101% 01 Jul 2012 30 Sep 2012
Q2 2012 -92% 01 Apr 2012 30 Jun 2012
Q1 2012 -81% 01 Jan 2012 31 Mar 2012

Viracta Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -71% -18% -33% 01 Jan 2023 31 Dec 2023
2022 -54% +40% +43% 01 Jan 2022 31 Dec 2022
2021 -94% -37% -64% 01 Jan 2021 31 Dec 2021
2020 -57% -7% -15% 01 Jan 2020 31 Dec 2020
2019 -50% +74% +60% 01 Jan 2019 31 Dec 2019
2018 -124% +5% +3.7% 01 Jan 2018 31 Dec 2018
2017 -129% -22% -21% 01 Jan 2017 31 Dec 2017
2016 -106% -15% -16% 01 Jan 2016 31 Dec 2016
2015 -91% -14% -18% 01 Jan 2015 31 Dec 2015
2014 -78% -8% -12% 01 Jan 2014 31 Dec 2014
2013 -69% +11% +14% 01 Jan 2013 31 Dec 2013
2012 -80% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.